Content about National Advertising Review Council

December 12, 2013

The National Advertising Division referred advertising claims made by Bremmen Clinical, for its Vysera-CLS weight-loss supplement, to the Federal Trade Commission for further review.

August 19, 2013

DrFuhrman.com informed the National Advertising Division that the company has discontinued certain advertising claims — including “anti-cancer” and cancer treatment claims — made for the company’s Immunotect dietary supplement.

May 13, 2013

The National Advertising Division recommended that UPSLabs discontinue all claims reviewed by NAD for the company’s Jack3d and Jack3d Micro dietary supplements. UPSLabs has agreed to discontinue the claims, NAD reported.

January 31, 2013

The Electronic Retailing Self-Regulation Program determined the National Weight Loss Institute can support general weight-loss claims made in direct-response advertising for Prevoxin, a dietary supplement intended to promote weight loss, but recommended the marketer modify or discontinue certain claims.

© 2014 Drug Store News. All Rights Reserved.